Updated Jul 16, 2026
CODE KENNETH REAY has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

| Role | Chief Science Officer, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | BLGO | BIOLARGO, INC. | A — Grant or award | 532.6K | $0.11 | $60K |
| 2026-04-02 | BLGO | BIOLARGO, INC. | A — Grant or award | 69.4K | $0.16 | $11K |
| 2025-07-14 | BLGO | BIOLARGO, INC. | A — Grant or award | 181.3K | $0.20 | $36K |
CODE KENNETH REAY is a corporate insider — currently tracked as Chief Science Officer, Director of BIOLARGO, INC. (BLGO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CODE KENNETH REAY profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.